BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37772551)

  • 21. Helical Tomotherapy of Lymph Node-negative Early-stage Breast Cancer After Breast-conserving Surgery: Long-term Results.
    Zwicker F; Klepper R; Hauswald H; Hoefel S; Raether L; Huber PE; Debus J; Schempp M
    Anticancer Res; 2023 May; 43(5):2041-2053. PubMed ID: 37097694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy.
    Yang JF; Lee MS; Lin CS; Chao HL; Chen CM; Lo CH; Fan CY; Tsao CC; Huang WY
    Medicine (Baltimore); 2016 Mar; 95(11):e3113. PubMed ID: 26986158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
    Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
    J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
    Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: Comparison with sequential boost in a randomized trial.
    Van Hulle H; Desaunois E; Vakaet V; Paelinck L; Schoepen M; Post G; Van Greveling A; Speleers B; Mareel M; De Neve W; Monten C; Deseyne P; Veldeman L
    Radiother Oncol; 2021 May; 158():62-66. PubMed ID: 33617910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
    Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
    Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
    Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
    Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant whole breast radiotherapy with simultaneous integrated boost to tumor bed with intensity modulated radiotherapy technique in elderly breast cancer patients.
    Chen KW; Hsu HT; Lin JF; Yeh HL; Yeh DC; Lin CY; Chan S; Hsieh HY
    Transl Cancer Res; 2020 Jan; 9(Suppl 1):S12-S22. PubMed ID: 35117944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
    Franceschini D; Fogliata A; Spoto R; Dominici L; Lo Faro L; Franzese C; Comito T; Lobefalo F; Reggiori G; Cozzi L; Sagona A; Gentile D; Scorsetti M
    Radiother Oncol; 2021 Nov; 164():50-56. PubMed ID: 34537289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
    Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
    Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma.
    Tao H; Wei Y; Huang W; Gai X; Li B
    Onco Targets Ther; 2016; 9():1865-73. PubMed ID: 27099518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials.
    Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D
    Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy.
    Harsolia A; Kestin L; Grills I; Wallace M; Jolly S; Jones C; Lala M; Martinez A; Schell S; Vicini FA
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1375-80. PubMed ID: 17544598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer.
    Stoian R; Exner JH; Gainey M; Erbes T; Gkika E; Popp I; Spohn SKB; Krug D; Juhasz-Böss I; Grosu AL; Sprave T
    Front Oncol; 2023; 13():1210879. PubMed ID: 37409247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomized comparison of simultaneous integrated boost with sequential boost intensity-modulated radiotherapy in locally advanced head and neck cancer.
    Mani N; Aggarwal SK; Kumar I; Mandal A; Jaiswal G; Ranjan R; Jaiswal AK; Gupta N; Singh A; Mourya A; Aggarwal LM; Choudhary S
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S455-S459. PubMed ID: 36511003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost.
    Kim M; Lee NK; Lee S; Hwang J
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
    Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
    Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.
    Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T
    Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.